Cephalon Drops Nuvigil Patent Suit Against Teva

Law360, New York (May 11, 2011, 5:30 PM EDT) -- Cephalon Inc. dropped its patent infringement suit in Delaware against Teva Pharmaceuticals USA Inc. on Wednesday, resolving one of several cases in a multidistrict litigation over the narcolepsy drug Nuvigil.

U.S. District Judge Gregory M. Sleet signed off on a stipulation and order dismissing the case, which had been brought by Cephalon and Cephalon France in December 2009.

Cephalon's original complaint asserted three patents, but the plaintiffs dropped their claims with respect to two of those in May 2010. The dismissal follows Teva amending the certification...
To view the full article, register now.